---
id: 1024415069151453185
author: yudapearl
published_date: 2018-07-31 22:02:39 +00:00
conversation_id: 1023798512985812992
in_reply_to: 1024363319233339397
retweet: None
quoted_tweet: None
type: tweet
---

@EpiEllie It buys us two things (at least). First, Investigators often switch their target "outcome", eg., to estimate side effects. Knowing what do(x) does to everyone minimizes re-computatioin. Second, knowing who is affected by do(x) will be crucial in defining counterfactuals (ch8)

### Metadata

Author: [[@yudapearl]]
Conversation: [[conversation-1023798512985812992]]
In reply to: [[1024363319233339397]]
Retweet of: [[None]]
Quoted tweet: [[None]]
